Evidence map›Paper›PMID 39881785›Full record

ArticleAddictive behaviors reports2025

Prevalence and determinants of tobacco use among school-going adolescents in 53 African countries: Evidence from the Global Youth Tobacco Survey.

Retselisitsoe Pokothoane, Terefe Gelibo Agerfa, Christus Cito Miderho, Noreen Dadirai Mdege

Abstract read
In one paragraph

Article in Addictive behaviors reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Retselisitsoe PokothoaneDevelopment Gateway: an IREX Venture, Washington, DC, United States.
Terefe Gelibo AgerfaDevelopment Gateway: an IREX Venture, Washington, DC, United States.
Christus Cito MiderhoDépartement d'Agro-Vétérinaire, Institut Supérieur Pédagogique de Bukavu (ISP/Bukavu), BP 854 Bukavu, Democratic Republic of the Congo.
Noreen Dadirai MdegeDevelopment Gateway: an IREX Venture, Washington, DC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tobacco use typically begins during adolescence. There is a lack of comprehensive evidence on the use of different tobacco products among adolescents in Africa. Aims and Methods: We used the most recent Global Youth Tobacco Surveys from 53 African countries, covering 2003-2020, to estimate the overall and gender-specific prevalence of each type of tobacco product by country, Africa region, World Bank income group, and age group among adolescents aged 11-17 years. We further used Logit regressions to assess the determinants of using different tobacco products. Results: The overall prevalence of any tobacco use among adolescents was 14.3 % [95 % CI: 13.5, 15.3]. Specifically, the prevalence for cigarettes was 6.4 % [95 % CI: 5.9, 7.0], for other smoked tobacco was 6.7 % [95 % CI: 6.0, 7.4], for smokeless tobacco use was 6.4 % [95 % CI: 5.9, 6.9], and for shisha smoking was 5.2 % [95 % CI: 4.4, 6.1]. The prevalence of dual use of smoked and smokeless tobacco was 3.0 % [95 % CI: 2.8, 3.2], and that of shisha and cigarettes was 1.5 % [95 % CI: 1.2, 2.0]. Any tobacco use prevalence was higher among boys (17.4 %) than girls (10.6 %). Seeing health warnings about tobacco dangers, exposure to smoking at home and school, the age restriction to tobacco purchases, and peer pressure were positively associated with the use of all tobacco products. Being a female was negatively associated with tobacco use across all products. Conclusions: Policymakers should prioritize implementing large pictorial health warnings about tobacco dangers covering the entire packaging of different products.

Indexed as

AdolescentsAfricaCigarettesGYTSShishaTobacco

Identifiers

PMID39881785
PMCPMC11774806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.